Weiss Multi-Strategy Advisers LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$322,000
-20.5%
7,011
+14.8%
0.01%
-22.2%
Q4 2021$405,000
-29.2%
6,108
-33.4%
0.01%
-25.0%
Q3 2021$572,000
+31.8%
9,169
-9.0%
0.01%0.0%
Q3 2020$434,000
+100.9%
10,078
+101.1%
0.01%
+100.0%
Q2 2020$216,0005,0110.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders